ALERE INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 88 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-10-03: Reporting owner Uppaluri Renuka; Form 4; Security Employee Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2017-10-03: Reporting owner Roosevelt James Jr.; Form 4; Security Employee Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2017-10-03: Reporting owner Roosevelt James Jr.; Form 4; Security Employee Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2017-10-03: Reporting owner Roosevelt James Jr.; Form 4; Security Employee Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-10-03 | Uppaluri Renuka Officer (Senior VP, Global R&D) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −75,000 0 owned after | $45.47 exercise price | 2017-10-03 | |
| 2017-10-03 | Roosevelt James Jr. Director | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,000 0 owned after | $22.74 exercise price | 2017-10-03 | |
| 2017-10-03 | Roosevelt James Jr. Director | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −49,156 0 owned after | $29.55 exercise price | 2017-10-03 | |
| 2017-10-03 | Roosevelt James Jr. Director | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −41,685 0 owned after | $33.73 exercise price | 2017-10-03 | |
| 2017-10-03 | QUELCH JOHN Director | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −41,336 0 owned after | $29.55 exercise price | 2017-10-03 | |
| 2017-10-03 | QUELCH JOHN Director | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −56,274 0 owned after | $33.73 exercise price | 2017-10-03 | |
| 2017-10-03 | Powers Gregg J Director | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −39,820 0 owned after | $33.73 exercise price | 2017-10-03 | |
| 2017-10-03 | Pelossof Avi Officer (GlobalPres, Infectious Disease) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $19.15 exercise price | 2017-10-03 | |
| 2017-10-03 | Pelossof Avi Officer (GlobalPres, Infectious Disease) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,500 0 owned after | $18.91 exercise price | 2017-10-03 | |
| 2017-10-03 | Pelossof Avi Officer (GlobalPres, Infectious Disease) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −14,081 0 owned after | $35.58 exercise price | 2017-10-03 | |
| 2017-10-03 | Pelossof Avi Officer (GlobalPres, Infectious Disease) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,000 0 owned after | $38.64 exercise price | 2017-10-03 | |
| 2017-10-03 | Pelossof Avi Officer (GlobalPres, Infectious Disease) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,000 0 owned after | $26.06 exercise price | 2017-10-03 | |
| 2017-10-03 | Pelossof Avi Officer (GlobalPres, Infectious Disease) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −50,000 0 owned after | $19.20 exercise price | 2017-10-03 | |
| 2017-10-03 | Pelossof Avi Officer (GlobalPres, Infectious Disease) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −25,000 0 owned after | $33.73 exercise price | 2017-10-03 | |
| 2017-10-03 | Pelossof Avi Officer (GlobalPres, Infectious Disease) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −45,000 0 owned after | $45.47 exercise price | 2017-10-03 | |
| 2017-10-03 | Pelossof Avi Officer (GlobalPres, Infectious Disease) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,000 0 owned after | $38.01 exercise price | 2017-10-03 | |
| 2017-10-03 | Pelossof Avi Officer (GlobalPres, Infectious Disease) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,125 0 owned after | $25.43 exercise price | 2017-10-03 | |
| 2017-10-03 | Pelossof Avi Officer (GlobalPres, Infectious Disease) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −14,250 0 owned after | $25.68 exercise price | 2017-10-03 | |
| 2017-10-03 | Pelossof Avi Officer (GlobalPres, Infectious Disease) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,000 0 owned after | $36.74 exercise price | 2017-10-03 | |
| 2017-10-03 | Nawana Namal Director, Officer (Chief Executive Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −200,000 0 owned after | $18.50 exercise price | 2017-10-03 | |
| 2017-10-03 | Nawana Namal Director, Officer (Chief Executive Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −300,000 0 owned after | $45.47 exercise price | 2017-10-03 | |
| 2017-10-03 | Nawana Namal Director, Officer (Chief Executive Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −100,000 0 owned after | $39.97 exercise price | 2017-10-03 | |
| 2017-10-03 | Nawana Namal Director, Officer (Chief Executive Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −23,077 0 owned after | $25.68 exercise price | 2017-10-03 | |
| 2017-10-03 | McKillop Thomas Director | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −53,756 0 owned after | $33.73 exercise price | 2017-10-03 | |
| 2017-10-03 | MARKISON BRIAN A Director | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −53,756 0 owned after | $33.73 exercise price | 2017-10-03 | |
| 2017-10-03 | Malkani Sanjay Officer (Global Pres., Toxicology) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,133 0 owned after | $35.58 exercise price | 2017-10-03 | |
| 2017-10-03 | Malkani Sanjay Officer (Global Pres., Toxicology) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $38.01 exercise price | 2017-10-03 | |
| 2017-10-03 | Malkani Sanjay Officer (Global Pres., Toxicology) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,000 0 owned after | $38.64 exercise price | 2017-10-03 | |
| 2017-10-03 | Malkani Sanjay Officer (Global Pres., Toxicology) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $37.14 exercise price | 2017-10-03 | |
| 2017-10-03 | Malkani Sanjay Officer (Global Pres., Toxicology) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −25,000 0 owned after | $19.20 exercise price | 2017-10-03 | |
| 2017-10-03 | Malkani Sanjay Officer (Global Pres., Toxicology) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −25,000 0 owned after | $33.73 exercise price | 2017-10-03 | |
| 2017-10-03 | Malkani Sanjay Officer (Global Pres., Toxicology) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −45,000 0 owned after | $45.47 exercise price | 2017-10-03 | |
| 2017-10-03 | Malkani Sanjay Officer (Global Pres., Toxicology) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,040 0 owned after | $44.64 exercise price | 2017-10-03 | |
| 2017-10-03 | Malkani Sanjay Officer (Global Pres., Toxicology) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,500 0 owned after | $26.06 exercise price | 2017-10-03 | |
| 2017-10-03 | Malkani Sanjay Officer (Global Pres., Toxicology) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,500 0 owned after | $18.91 exercise price | 2017-10-03 | |
| 2017-10-03 | Malkani Sanjay Officer (Global Pres., Toxicology) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,900 0 owned after | $25.43 exercise price | 2017-10-03 | |
| 2017-10-03 | Malkani Sanjay Officer (Global Pres., Toxicology) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $25.68 exercise price | 2017-10-03 | |
| 2017-10-03 | Malkani Sanjay Officer (Global Pres., Toxicology) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,375 0 owned after | $36.74 exercise price | 2017-10-03 | |
| 2017-10-03 | LEVY JOHN F Director | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −49,156 0 owned after | $29.55 exercise price | 2017-10-03 | |
| 2017-10-03 | LEVY JOHN F Director | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −56,274 0 owned after | $33.73 exercise price | 2017-10-03 | |
| 2017-10-03 | Hinrichs James F. Officer (Executive VP, CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −108,118 0 owned after | $47.48 exercise price | 2017-10-03 | |
| 2017-10-03 | Hinrichs James F. Officer (Executive VP, CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −250,000 0 owned after | $50.08 exercise price | 2017-10-03 | |
| 2017-10-03 | Hargadon Robert Bernard Officer (SVP, Global Human Resources) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,000 0 owned after | $29.55 exercise price | 2017-10-03 | |
| 2017-10-03 | Hargadon Robert Bernard Officer (SVP, Global Human Resources) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,000 0 owned after | $26.06 exercise price | 2017-10-03 | |
| 2017-10-03 | Hargadon Robert Bernard Officer (SVP, Global Human Resources) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −35,000 0 owned after | $45.47 exercise price | 2017-10-03 | |
| 2017-10-03 | Hargadon Robert Bernard Officer (SVP, Global Human Resources) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −800 0 owned after | $25.43 exercise price | 2017-10-03 | |
| 2017-10-03 | Hargadon Robert Bernard Officer (SVP, Global Human Resources) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,600 0 owned after | $25.68 exercise price | 2017-10-03 | |
| 2017-10-03 | Hargadon Robert Bernard Officer (SVP, Global Human Resources) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,250 0 owned after | $36.74 exercise price | 2017-10-03 | |
| 2017-10-03 | Guerdan Melissa Officer (SVP, Global Quality & Reg.) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,148 0 owned after | $18.78 exercise price | 2017-10-03 | |
| 2017-10-03 | Guerdan Melissa Officer (SVP, Global Quality & Reg.) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,000 0 owned after | $33.73 exercise price | 2017-10-03 | |
| 2017-10-03 | Guerdan Melissa Officer (SVP, Global Quality & Reg.) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −35,000 0 owned after | $45.47 exercise price | 2017-10-03 | |
| 2017-10-03 | Guerdan Melissa Officer (SVP, Global Quality & Reg.) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,063 0 owned after | $25.68 exercise price | 2017-10-03 | |
| 2017-10-03 | Guerdan Melissa Officer (SVP, Global Quality & Reg.) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,250 0 owned after | $36.74 exercise price | 2017-10-03 | |
| 2017-10-03 | GOLDBERG CAROL R Director | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −33,515 0 owned after | $29.55 exercise price | 2017-10-03 | |
| 2017-10-03 | GOLDBERG CAROL R Director | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −41,685 0 owned after | $33.73 exercise price | 2017-10-03 | |
| 2017-10-03 | Gladwell Mark Officer (Senior VP, Global Operations) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,291 0 owned after | $35.58 exercise price | 2017-10-03 | |
| 2017-10-03 | Gladwell Mark Officer (Senior VP, Global Operations) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,000 0 owned after | $39.78 exercise price | 2017-10-03 | |
| 2017-10-03 | Gladwell Mark Officer (Senior VP, Global Operations) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,737 0 owned after | $26.06 exercise price | 2017-10-03 | |
| 2017-10-03 | Gladwell Mark Officer (Senior VP, Global Operations) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −35,000 0 owned after | $45.47 exercise price | 2017-10-03 | |
| 2017-10-03 | Gladwell Mark Officer (Senior VP, Global Operations) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −500 0 owned after | $25.43 exercise price | 2017-10-03 | |
| 2017-10-03 | Gladwell Mark Officer (Senior VP, Global Operations) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,750 0 owned after | $25.68 exercise price | 2017-10-03 | |
| 2017-10-03 | Gladwell Mark Officer (Senior VP, Global Operations) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,500 0 owned after | $36.74 exercise price | 2017-10-03 | |
| 2017-10-03 | Cramp Daniella Officer (Global Pres., Cardiometabolic) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $19.15 exercise price | 2017-10-03 | |
| 2017-10-03 | Cramp Daniella Officer (Global Pres., Cardiometabolic) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,500 0 owned after | $18.91 exercise price | 2017-10-03 | |
| 2017-10-03 | Cramp Daniella Officer (Global Pres., Cardiometabolic) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −14,709 0 owned after | $35.58 exercise price | 2017-10-03 | |
| 2017-10-03 | Cramp Daniella Officer (Global Pres., Cardiometabolic) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,000 0 owned after | $38.64 exercise price | 2017-10-03 | |
| 2017-10-03 | Cramp Daniella Officer (Global Pres., Cardiometabolic) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −40,000 0 owned after | $26.06 exercise price | 2017-10-03 | |
| 2017-10-03 | Cramp Daniella Officer (Global Pres., Cardiometabolic) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −50,000 0 owned after | $19.20 exercise price | 2017-10-03 | |
| 2017-10-03 | Cramp Daniella Officer (Global Pres., Cardiometabolic) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −25,000 0 owned after | $33.73 exercise price | 2017-10-03 | |
| 2017-10-03 | Cramp Daniella Officer (Global Pres., Cardiometabolic) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −45,000 0 owned after | $45.47 exercise price | 2017-10-03 | |
| 2017-10-03 | Cramp Daniella Officer (Global Pres., Cardiometabolic) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $38.01 exercise price | 2017-10-03 | |
| 2017-10-03 | Cramp Daniella Officer (Global Pres., Cardiometabolic) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,500 0 owned after | $25.43 exercise price | 2017-10-03 | |
| 2017-10-03 | Cramp Daniella Officer (Global Pres., Cardiometabolic) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $25.68 exercise price | 2017-10-03 | |
| 2017-10-03 | Cramp Daniella Officer (Global Pres., Cardiometabolic) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,000 0 owned after | $36.74 exercise price | 2017-10-03 | |
| 2017-10-03 | Chiniara Ellen Officer (GC, Chief Ethics Officer&Sec) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,331 0 owned after | $35.58 exercise price | 2017-10-03 | |
| 2017-10-03 | Chiniara Ellen Officer (GC, Chief Ethics Officer&Sec) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,000 0 owned after | $38.01 exercise price | 2017-10-03 | |
| 2017-10-03 | Chiniara Ellen Officer (GC, Chief Ethics Officer&Sec) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $26.06 exercise price | 2017-10-03 | |
| 2017-10-03 | Chiniara Ellen Officer (GC, Chief Ethics Officer&Sec) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −35,000 0 owned after | $45.47 exercise price | 2017-10-03 | |
| 2017-10-03 | Chiniara Ellen Officer (GC, Chief Ethics Officer&Sec) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,250 0 owned after | $37.42 exercise price | 2017-10-03 | |
| 2017-10-03 | Chiniara Ellen Officer (GC, Chief Ethics Officer&Sec) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −975 0 owned after | $25.43 exercise price | 2017-10-03 | |
| 2017-10-03 | Chiniara Ellen Officer (GC, Chief Ethics Officer&Sec) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,788 0 owned after | $25.68 exercise price | 2017-10-03 | |
| 2017-10-03 | Chiniara Ellen Officer (GC, Chief Ethics Officer&Sec) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,500 0 owned after | $36.74 exercise price | 2017-10-03 | |
| 2017-10-03 | BRIDGEN JOHN Officer (Sr VP, Business Development) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,500 0 owned after | $26.06 exercise price | 2017-10-03 | |
| 2017-10-03 | BRIDGEN JOHN Officer (Sr VP, Business Development) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −35,000 0 owned after | $45.47 exercise price | 2017-10-03 | |
| 2017-10-03 | BRIDGEN JOHN Officer (Sr VP, Business Development) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,788 0 owned after | $25.68 exercise price | 2017-10-03 | |
| 2017-10-03 | BRIDGEN JOHN Officer (Sr VP, Business Development) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −750 0 owned after | $36.74 exercise price | 2017-10-03 | |
| 2017-08-31 | Cramp Daniella Officer (Global Pres., Cardiometabolic) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,308 0 owned after | $48.14 exercise price | 2017-09-05 | |
| 2017-08-31 | Cramp Daniella Officer (Global Pres., Cardiometabolic) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,692 0 owned after | $48.14 exercise price | 2017-09-05 |